Radjenović J, Jelić A, Petrović M, Barceló D
Department of Environmental Chemistry, IDAEA-CSIC, c/Jordi Girona 18-26, 08034, Barcelona, Spain.
Anal Bioanal Chem. 2009 Mar;393(6-7):1685-95. doi: 10.1007/s00216-009-2604-4. Epub 2009 Jan 27.
In this study, we aimed at optimizing a sensitive and reliable method for a simultaneous determination of 31 pharmaceuticals belonging to predominant therapeutic classes identified in different types of sewage sludge proceeding from conventional and advanced wastewater treatment. Freeze-dried sewage sludge was extracted by pressurized liquid extraction technique using accelerated solvent extractor Dionex 300. In order to minimize interferences with matrix components and to preconcentrate target analytes, solid phase extraction was introduced in the method as a clean-up step. The entire method was validated for linearity, precision, accuracy, and method detection limits (MDLs). The method turned out to be specific, sensitive, and reliable for the analysis of sludge of different composition, type, and retention time in the process. The developed sample preparation protocol and previously published method for LC-MS/MS analysis (Gros et al., Talanta 70:678-690, 2006) were successfully applied to monitor the target pharmaceuticals in different types of sewage sludge, i.e., primary sludge, secondary sludge, treated sludge, and sludge proceeding from pilot-scale membrane bioreactors (MBRs) operating in parallel to the conventional activated sludge treatment. Among the investigated pharmaceuticals, 20 were detected in the sludge proceeding from full-scale installations, whereas the MBR sludge concentrations were below MDLs for several compounds. The highest concentrations were recorded for treated and primary sludge. For example, the mean concentration of ibuprofen in the digested sludge was 299.3 +/- 70.9 ng g(-1) dw, whereas in the primary sludge, it was enriched up to 741.1 ng g(-1) dw. Other pharmaceuticals detected at relatively high concentrations were diclofenac, erythromycin, glibenclamide, ketoprofen, ofloxacin, azithromycin (up to 380.7, 164.2, 190.7, 336.3, 454.7, 299.6 ng g(-1) dw in the primary sludge, respectively), gemfibrozil, loratidine, and fluoxetine (up to 189.1, 189.7 and 174.1 ng g(-1) dw in the treated sludge, respectively).
在本研究中,我们旨在优化一种灵敏且可靠的方法,用于同时测定来自常规和深度污水处理的不同类型污水污泥中31种属于主要治疗类别的药物。采用Dionex 300加速溶剂萃取仪,通过加压液体萃取技术对冻干的污水污泥进行萃取。为了尽量减少与基质成分的干扰并预富集目标分析物,该方法引入固相萃取作为净化步骤。对整个方法的线性、精密度、准确度和方法检出限(MDLs)进行了验证。结果表明,该方法对于分析不同组成、类型和处理过程中停留时间的污泥具有特异性、灵敏性和可靠性。所开发的样品制备方案和先前发表的LC-MS/MS分析方法(Gros等人,《塔兰塔》70:678 - 690,2006年)成功应用于监测不同类型污水污泥中的目标药物,即初沉污泥、二沉污泥、处理后污泥以及与常规活性污泥处理并行运行的中试规模膜生物反应器(MBR)产生的污泥。在所研究的药物中,在实际规模设施产生的污泥中检测到20种,而MBR污泥中几种化合物的浓度低于方法检出限。处理后污泥和初沉污泥中的浓度最高。例如,消化污泥中布洛芬的平均浓度为299.3±70.9 ng g(-1)干重,而在初沉污泥中,其富集至高达741.1 ng g(-1)干重。其他检测到浓度相对较高的药物分别为双氯芬酸、红霉素、格列本脲、酮洛芬、氧氟沙星、阿奇霉素(初沉污泥中分别高达380.7、164.2、190.7、336.3、454.7、299.6 ng g(-1)干重)、吉非贝齐、氯雷他定和氟西汀(处理后污泥中分别高达189.1、189.7和174.1 ng g(-1)干重)。